Physician profile
Gregory D Cook
NPI 1114135092
$1,948.68
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,935 · 2023: $13.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $387.47 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $212.78 | 2019 | |
| Lilly USA, LLC | $177.75 | 2019 | |
| Amgen INC. | $167.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $156.84 | 2019 | |
| Merck Sharp & Dohme LLC | $129.63 | 2019 | |
| Tandem Diabetes Care, INC. | $104.51 | 2019 | |
| Antares Pharma, INC. | $88.99 | 2019 | |
| Dexcom, INC. | $69.08 | 2019 | |
| Abbott Laboratories | $68.14 | 2019 | |
| Valeritas, INC. | $67.32 | 2019 | |
| Insulet Corporation | $56.16 | 2019 | |
| Ibsa Pharma INC. | $43.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $36.73 | 2019 | |
| Corcept Therapeutics | $33.93 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $31.52 | 2019 | |
| Pfizer INC. | $28.08 | 2019 | |
| Amneal Pharmaceuticals LLC | $25.82 | 2019 | |
| Becton, Dickinson and Company | $22.10 | 2019 | |
| Medtronic Minimed, INC. | $14.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.48 | 2019 | |
| Abbvie INC. | $13.32 | 2023 | Vraylar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.